JPS52133980A - Medical treatment using 22iminothiazolidines and thiazolines - Google Patents

Medical treatment using 22iminothiazolidines and thiazolines

Info

Publication number
JPS52133980A
JPS52133980A JP5003877A JP5003877A JPS52133980A JP S52133980 A JPS52133980 A JP S52133980A JP 5003877 A JP5003877 A JP 5003877A JP 5003877 A JP5003877 A JP 5003877A JP S52133980 A JPS52133980 A JP S52133980A
Authority
JP
Japan
Prior art keywords
thiazolines
medical treatment
medical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5003877A
Other languages
English (en)
Japanese (ja)
Inventor
Aaru Hantaa Nooman
Esu Ruunii Kurarensu
Rokatsuchi Jiyoshiyua
Jiee Kuragoo Jiyuniya Edowaado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS52133980A publication Critical patent/JPS52133980A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
JP5003877A 1976-05-03 1977-05-02 Medical treatment using 22iminothiazolidines and thiazolines Pending JPS52133980A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/682,802 US4029803A (en) 1976-05-03 1976-05-03 Method of treatment with 2-iminothiazolidines and thiazolines

Publications (1)

Publication Number Publication Date
JPS52133980A true JPS52133980A (en) 1977-11-09

Family

ID=24741190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5003877A Pending JPS52133980A (en) 1976-05-03 1977-05-02 Medical treatment using 22iminothiazolidines and thiazolines

Country Status (13)

Country Link
US (1) US4029803A (enExample)
JP (1) JPS52133980A (enExample)
AU (1) AU513234B2 (enExample)
BE (1) BE854171A (enExample)
DE (1) DE2719576A1 (enExample)
FR (1) FR2350099A1 (enExample)
GB (1) GB1526666A (enExample)
IE (1) IE45040B1 (enExample)
IL (1) IL51934A (enExample)
NL (1) NL7704320A (enExample)
NZ (1) NZ183929A (enExample)
PH (1) PH13497A (enExample)
ZA (1) ZA772615B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191408B (en) * 1984-04-25 1987-02-27 Egis Gyogyszergyar,Hu Process for preparing new imino-thiazolidine derivatives
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
UA120343C2 (uk) 2012-12-17 2019-11-25 Періон Сайєнсіз, Інк. Похідні хлорпіразинкарбоксаміду, які мають активність блокування епітеліальних натрієвих каналів
CN108658876A (zh) 2012-12-17 2018-10-16 帕里昂科学公司 3,5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Also Published As

Publication number Publication date
US4029803A (en) 1977-06-14
DE2719576A1 (de) 1977-11-24
GB1526666A (en) 1978-09-27
ZA772615B (en) 1978-12-27
PH13497A (en) 1980-05-23
AU513234B2 (en) 1980-11-20
FR2350099B1 (enExample) 1979-03-02
IL51934A0 (en) 1977-06-30
NL7704320A (nl) 1977-11-07
IE45040B1 (en) 1982-06-02
IL51934A (en) 1980-01-31
IE45040L (en) 1977-11-03
NZ183929A (en) 1981-10-19
AU2462977A (en) 1978-11-02
BE854171A (fr) 1977-11-03
FR2350099A1 (fr) 1977-12-02

Similar Documents

Publication Publication Date Title
GB1541155A (en) Medical glove and method
AU2438977A (en) Mesotherapeutic treatment
AU1880276A (en) Skin treatment appliance
JPS5312415A (en) Medical recipe and method
JPS5334389A (en) Medical and surgical dressing
DE2861878D1 (en) Device for the treatment of uremic patients
JPS5312851A (en) Novel phenoxyhydroxypropylamine* its preparation and its application for medical treatment
JPS52133980A (en) Medical treatment using 22iminothiazolidines and thiazolines
JPS5487584A (en) Thermometer for medical treatment
JPS52151730A (en) Medical composition for treating and preventing relapsic thrombus
JPS5441847A (en) Pseudotrisaccharides*their manufacture and their medical use
AU3576478A (en) Dental treatment
JPS52150784A (en) Treatment of chromiummcontaining wastes
GB1546480A (en) Disinfectant and sterilizing preparations
PH14777A (en) Heterocyclopyrimidine and therapeutic process thereof
JPS5436083A (en) Medical catheter
JPS5341085A (en) Dental treatment chair
JPS5391121A (en) Sterilizing agent and use thereof
JPS5581640A (en) Ultrasoniccwave medical treatment device
JPS5291589A (en) Dental treatment chair
JPS5554953A (en) Hottwind and colddwind medical treatment device
JPS5454488A (en) Magnetic medical treatment device
JPS52105218A (en) Waterreczema treating medicine
JPS5356326A (en) Waterreczema treating medicine neoonagatol
JPS53114286A (en) Medical catheter